KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Other financing activities (2016 - 2025)

Historic Other financing activities for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to -$4.0 million.

  • Thermo Fisher Scientific's Other financing activities fell 10597.01% to -$4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$18.0 million, marking a year-over-year decrease of 10796.46%. This contributed to the annual value of $195.0 million for FY2024, which is 24821.43% up from last year.
  • According to the latest figures from Q3 2025, Thermo Fisher Scientific's Other financing activities is -$4.0 million, which was down 10597.01% from -$42.0 million recorded in Q2 2025.
  • Over the past 5 years, Thermo Fisher Scientific's Other financing activities peaked at $110.0 million during Q1 2024, and registered a low of -$42.0 million during Q2 2025.
  • Moreover, its 5-year median value for Other financing activities was $18.0 million (2023), whereas its average is $16.1 million.
  • In the last 5 years, Thermo Fisher Scientific's Other financing activities tumbled by 27000.0% in 2022 and then skyrocketed by 77500.0% in 2024.
  • Quarter analysis of 5 years shows Thermo Fisher Scientific's Other financing activities stood at $79.0 million in 2021, then plummeted by 74.68% to $20.0 million in 2022, then decreased by 30.0% to $14.0 million in 2023, then plummeted by 221.43% to -$17.0 million in 2024, then surged by 76.47% to -$4.0 million in 2025.
  • Its Other financing activities stands at -$4.0 million for Q3 2025, versus -$42.0 million for Q2 2025 and $45.0 million for Q1 2025.